| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |